ArticleMetabolomics : Official journal of the Metabolomic Society2026
Metabolomic profiling and vitamin D pathway investigation in diabetic foot ulcer patients.
Article in Metabolomics : Official journal of the Metabolomic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiabetic foot ulcer (DFU) is a severe complication of diabetes mellitus (DM) characterized by chronic inflammation, impaired wound repair, and systemic metabolic imbalance. This study aimed to identify plasma metabolite signatures associated with DFU and investigate altered metabolic pathways that may serve as potential biomarker.
objectiveThe study aims to identify metabolic alterations and potential biomarkers associated with diabetic foot ulcers, with a focus on the role of vitamin D.
methodsWe performed an LC/MS/MS-based untargeted metabolomic profiling on plasma sample from DFU patients (n = 22), DM patients without foot ulcers (n = 22), and healthy controls (n = 10). The mean age group was 54years, with comparable gender (male = 9; female = 13) distribution in DFU and DM groups.
resultsPLS-DA showed clear metabolic separation between DFU and DM groups. DFU group showed elevated levels of aspartic acid, glutamic acid, taurine, and D-fructose, indicating altered hyperglycemia induced metabolic stress. In contrast, calcitriol and glutathione were significantly reduced (P < 0.01), suggesting compromised antioxidant capacity and immune metabolic regulation. Downregulation of sphingosine-1-phosphate (SIP), L-palmitoylcarnitine, and docosahexaenoic acid (DHA) suggest disruptions in mitochondrial dynamics, and wound healing. Elevated taurine, potentially regulated by the vitamin D receptor (VDR), links vitamin D to tissue homeostasis.
conclusionsThis study reveals coordinated disturbances in lipid metabolism, antioxidant defense, and vitamin D signaling in DFU. The identified metabolite signatures highlight pathway-level metabolic alterations associated with impaired wound healing. Our findings suggest that the biological impact of vitamin D in DFU may depend not only on supplementation, but also on its downstream conversion to calcitriol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.